Belinus Bt.
- Address
- lock Available on a paid plan
Cardiovascular Diseases
At Belinus Bt. in Debrecen, research in Cardiovascular Diseases focuses mainly on Atrial Fibrillation and related bleeding risk management. The trials are designed to compare treatments and improve the safety of care for people with heart rhythm disorders.
- Evaluating a new therapy for Atrial Fibrillation against standard anticoagulation
- Studying the balance between preventing clots and reducing bleeding complications
This work aims to support better treatment choices for patients who need long-term cardiovascular protection.
Nutritional and Metabolic Diseases
Clinical trials in Nutritional and Metabolic Diseases cover Type 2 diabetes, Obesity, Overweight, Hyperlipidemia, and Severe Hypertriglyceridemia. The studies are testing new approaches to improve blood sugar control, reduce body weight, and lower harmful blood lipids.
- Assessing therapies for Type 2 diabetes when diet and exercise are not enough
- Testing treatments for Obesity and Overweight to support weight loss
- Evaluating options for Hyperlipidemia and severe triglyceride reduction
The overall goal is to find more effective ways to manage metabolic disease and its common complications.
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Research in Congenital, Hereditary, and Neonatal Diseases and Abnormalities is represented more broadly at this site and may reflect trials with complex or overlapping disease areas rather than a single condition. The focus is on understanding treatment effects in patients with chronic health problems that can involve inherited or early-life risk factors.
- Exploring broader disease patterns linked to long-term metabolic and cardiovascular risk
- Supporting research that may inform care across multiple patient groups
This area adds depth to the site’s portfolio by connecting specialized research with wider clinical needs.
Otorhinolaryngologic Diseases
The site also includes Otorhinolaryngologic Diseases within its research profile, although this appears less prominent than the metabolic and cardiovascular studies. The available trials suggest a broader clinical environment that may support diverse patient populations and related health concerns.
- Contributing to a varied clinical research portfolio
- Supporting investigation of conditions outside the main metabolic focus
These studies help broaden understanding of treatment needs across different medical specialties.
Other and Unspecified Research Areas
Some trials at Belinus Bt. fall into categories that are not fully specified, showing a flexible research program that can adapt to different clinical questions. These studies still center on practical goals such as testing new therapies, improving disease control, and comparing treatment effectiveness.
- Investigating new options for chronic disease management
- Comparing therapies with placebo or established treatments
- Generating evidence to guide everyday clinical decisions
Together, these projects reflect an active site contributing to both targeted and broader clinical research in Hungary.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 therapeutic areas and 15 of 21 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Merck Sharp & Dohme LLC2trials
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 332 other sites in Hungary
Therapeutic Area Benchmark — Hungary
Select a therapeutic area to compare against other sites in Hungary.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Hungary
Market Share
Country: Hungary
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Belinus Bt.
lock Showing 1 of 13 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3 Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of MK-0616 in Reducing Major Adverse Cardiovascular Events in Participants at High Cardiovascular Risk | Merck Sharp & Dohme LLC | Phase III | Not Recruiting | Jun 2024 | — |
IMP list
lock Showing 1 of 21 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Apixaban | 2 | Unknown | 2022-11-24 | 2023-08-23 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.